• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. CUSTOM PELVIS LEFT; HIP COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. CUSTOM PELVIS LEFT; HIP COMPONENT Back to Search Results
Model Number CP7A0919
Device Problem Insufficient Information (3190)
Patient Problem Unspecified Infection (1930)
Event Date 05/05/2020
Event Type  Injury  
Manufacturer Narrative
This event will be updated once the investigation is complete.Trends will be evaluate.
 
Event Description
Allegedly, patient was revised due to infection.The cement, constrained liner and ceramic head were remove.They washed everything as completely as possible then cement in a new constrained liner and head then plastics were covered.
 
Manufacturer Narrative
Void record, the component is not commercially available by mpo.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUSTOM PELVIS LEFT
Type of Device
HIP COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key10085671
MDR Text Key191965085
Report Number3010536692-2020-00377
Device Sequence Number1
Product Code LZO
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 09/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Model NumberCP7A0919
Device Catalogue NumberCP7A0919
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date05/06/2020
Initial Date Manufacturer Received 05/06/2020
Initial Date FDA Received05/25/2020
Supplement Dates Manufacturer Received05/06/2020
Supplement Dates FDA Received09/04/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age35 YR
-
-